Intelligent Quality Audits
RCI’s proprietary iQA tools and process work to identify potential revenue cycle failure points that adversely affect optimal billing performance.
During the iQA process, RCI evaluates the full medication revenue cycle to identify revenue opportunities and billing compliance risks.
Audits begin with on-site assessments of charge capture workflows and EMR documentation, continue through IT architecture build analysis, and include patient billing and pharmacy purchasing data analysis.
At the conclusion of the iQA process, RCI delivers detailed system level findings, prescriptive corrective action plans, and measurable gross revenue impacts, all within a Rapid Cycle Improvement time frame.